Teva's CEO on Why the Drugmaker Is Confident Despite Covid-19 | Barron's
Teva back on the hook for $235M to GSK for heart drug infringement | Fierce Pharma
Teva Pharmaceutical Is in Recovery - WSJ
利回りのない世界、希望的観測抱く投資家 | WSJ PickUp | ダイヤモンド・オンライン
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Teva Settles Foreign Corruption Probe for $519 Million - WSJ
Teva Makes $15 Billion Settlement Offer in U.S. Opioid Case, Report Says | Ctech
Teva Gives Downbeat Earnings Forecast - WSJ
Israeli drug manufacturer Teva at center of anti-trust lawsuit brought by 44 states - Jewish Telegraphic Agency
King of Generics Pushes Into Biotech Drugs - WSJ
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Stock Market Live Updates: Markets close at record highs
Teva's Indictment Came After Talks Faltered With Justice Department - WSJ
GitHub - CharlesBean/WSJTeva: TEvA Applied to WSJ
Teva Pharmaceutical Industries Ltd ADR (TEVA-N) Quote - The Globe and Mail
Teva found liable for fueling opioid addiction in New York | Mint
FDA Rejects Teva's Application For Huntington's Drug - WSJ
Teva, distributors sidestep Ohio opioid trial with last-minute deal: WSJ | Fierce Pharma
Teva Pharmaceutical's Sales Slump 18% - WSJ
P&G to name David Taylor CEO: WSJ | Reuters.com
Opioid Risk Smothers Drug Stocks - WSJ
Legislators Seek US FDA Input On Teva Proposed Opioid Settlement :: Pink Sheet
Johnson & Johnson, Teva, others face federal criminal probe into opioid sales: WSJ | Fierce Pharma
Teva in talks to buy Allergan big generic-drug unit: WSJ | Reuters.com
